Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. Sutures: The iconic Johnson & Johnson invention that revolutionized medicine
An infographic with fun facts about the history of Johnson & Johnson’s surgical sutures

Sutures: The iconic Johnson & Johnson invention that revolutionized medicine

To commemorate the month that the company first listed sutures in its 1887 inventory book, we’re unspooling fun facts about the ubiquitous medical innovation.

A common thread in Johnson & Johnson’s storied century-plus history is its commitment to innovation in healthcare. One of its most revolutionary inventions? The mass production of sterile surgical sutures, which forever changed the field of medicine, and helped improve the outcomes of patients going into the operating room for the better.

The revolutionary product first appeared in a Johnson & Johnson cash book (a business ledger listing inventory and expenditures) as “ligatures” in January 1887. Since then, suture innovation has continued at the company, leading to a long string of follow-up products that are changing the surgery game in their own right.

This infographic spins the full tale of the great history—and exciting future—of those signature sutures.

A graphic of surgical sutures

When you’ve been innovating for 139 years …

Discover more about the history of Johnson & Johnson.
Johnson & Johnson's new museum at its world headquarters in New Jersey
© Albert Vecerka/Esto. All rights reserved.

More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.